Fri, February 9, 2018
Thu, February 8, 2018
Wed, February 7, 2018

Douglas Miehm Initiated (AUPH) at Buy and Held Target at $9 on, Feb 8th, 2018

Douglas Miehm of RBC Capital, Initiated "Aurinia Pharmaceuticals Inc." (AUPH) at Buy and Held Target at $9 on, Feb 8th, 2018.

Douglas has made no other calls on AUPH in the last 4 months.



There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas


  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Increased Target to $14 on, Monday, October 23rd, 2017